Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNA vaccination in HIV-vertically infected children
2007-002359-18Phase 2Active
- Sponsor
- Swedish Institute for Infectious Disease Control
- Start
- Jul 2008
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of HIVIS-DNA vaccine in human immunodeficiency virus infection (HIV), sponsored by Swedish Institute for Infectious Disease Control. Primary endpoints: Grade 3+ toxicity related to immunization, Feasibility of topical HIV plasmid DNA immunization and 1 more. Started Jul 2008; status: active.
02
Drugs
HIVIS-DNA vaccine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-002359-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002359-18.